Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implanta

US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic arm. Founded by Elon Musk, the company said that the trial, named CONVOY, will operate with cross-enrolling from the company’s ongoing PRIME study (NCT06429735), which is being completed in the US.

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control using the N1 implant to an investigational assistive robotic arm," adding that it is "an important first step towards restoring not only digital freedom, but also physical freedom."